You are here

Study Evaluating Management of Patients With Moderate and Severe Psoriasis

Last updated on April 10, 2018

FOR MORE INFORMATION
Study Location
Madrid, , 28031 Spain
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Psoriasis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18+ years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

·Over 18 years of age.·Diagnosed with moderate or severe psoriasis.·Initiated treatment
with topical and/or systemic treatment between two and five years before enrollment in the
study. ·Has a clinical record at the dermatologist office.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

·Currently participating in a clinical study. ·Clinical record lacks minimum data required
for observational analysis.

NCT00894777
Pfizer
Completed
Study Evaluating Management of Patients With Moderate and Severe Psoriasis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.
Study Evaluating Management of Patients With Moderate and Severe Psoriasis
Management of Patients With Moderate and Severe Psoriasis Under Treatment With Topical and/or Systemic Drugs
This is an observational, naturalistic, multicenter, retrospective study to describe the therapeutic management of patients with moderate and severe psoriasis under treatment with topical and/or systemic drugs in usual clinical practice in Spain.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Retrospective
Not Provided
Not Provided
Probability Sample
Patients with moderate and severe psoriasis under treatment with topical and/or systemic drugs in usual clinical practice
Psoriasis
Other: Clinical record review
1
Patients with moderate and severe psoriasis under treatment with topical and/or systemic drugs
Intervention: Other: Clinical record review
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
469
November 2009
November 2009   (Final data collection date for primary outcome measure)

Main Inclusion Criteria:

·Over 18 years of age.·Diagnosed with moderate or severe psoriasis.·Initiated treatment with topical and/or systemic treatment between two and five years before enrollment in the study. ·Has a clinical record at the dermatologist office.

Main Exclusion Criteria:

·Currently participating in a clinical study. ·Clinical record lacks minimum data required for observational analysis.

Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Spain
 
 
NCT00894777
0881A6-4577
No
Not Provided
Not Provided
Director, Clinical Trial Disclosure Group, Wyeth
Wyeth is now a wholly owned subsidiary of Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Wyeth is now a wholly owned subsidiary of Pfizer
Wyeth is now a wholly owned subsidiary of Pfizer
November 2010

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now